Table 4.
Bivariate and multivariate analysis of variables associated with NCI among PLH attending at public health institution in Bahir Dar, Ethiopia, 2016 (n = 400).
| Neurocognitive impairment | ||||||
|---|---|---|---|---|---|---|
| Variable | Yes | No | COR (95%CI) | AOR (95%CI) | P-value | |
| Sex of respondent | Female | 168 | 65 | 0.56 (0.37,0.85) | 1.92 (1.24,2.97)* | 0.01 |
| HIV Clinical stage | Male | 99 | 68 | 1 | 1 | |
| Stage I | 98 | 56 | 1 | |||
| Opportunistic infection | Stage II | 14 | 55 | 0.92 (0.58,1.47) | ||
| Stage III/IV | 65 | 22 | 0.59 (0.33,1.06) | |||
| Yes | 79 | 26 | 0.57 (0.35,0.95) | |||
| No | 188 | 107 | 1 | |||
| Co- morbid medical diseases | Yes | 60 | 13 | 0.37 (0.19,0.70) | 2.28 (1.17,4.44)* | <0.01 |
| No | 207 | 120 | 1 | |||
| Treatment regimen | First-line | 208 | 117 | 1 | 1 | |
| Social support | Second-line | 59 | 16 | 2.07 (1.14,3.76) | 1.94 (1.03,3.63)* | 0.04 |
| poor | 58 | 26 | 0.51 (0.27,0.97) | |||
| medium | 164 | 68 | 0.47 (0.28,0.80) | |||
| strong | 45 | 39 | 1 | |||
*
P < 0.05.